Effect of SanOrg123781A, a synthetic hexadecasaccharide, on clot-bound thrombin and factor Xa in vitro and in vivo
- 1 September 2003
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (9) , 1959-1965
- https://doi.org/10.1046/j.1538-7836.2003.00358.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pharmacokinetics of New Synthetic Heparin MimeticsThrombosis and Haemostasis, 2002
- SR123781A, a Synthetic Heparin MimeticThrombosis and Haemostasis, 2001
- Human Thrombi Contain an Abundance of Active ThrombinThrombosis and Haemostasis, 2001
- Synthesis of thrombin-inhibiting heparin mimetics without side effectsNature, 1999
- Characterization of the Binding of Factor Xa to Fibrinogen/Fibrin Derivatives and Localization of the Factor Xa Binding Site on FibrinogenEuropean Journal of Biochemistry, 1995
- Importance of factor Xa in determining the procoagulant activity of whole-blood clots.Journal of Clinical Investigation, 1993
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.Proceedings of the National Academy of Sciences, 1989
- Localization of the binding site on fibrin for the secondary binding site of thrombinBiochemistry, 1988
- Thrombolysis with Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits with Experimental Jugular Vein Thrombosis. EFFECT OF MOLECULAR FORM AND DOSE OF ACTIVATOR, AGE OF THE THROMBUS, AND ROUTE OF ADMINISTRATIONJournal of Clinical Investigation, 1983